Clinical Research Directory
Browse clinical research sites, groups, and studies.
Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study
Sponsor: Istituto Ortopedico Rizzoli
Summary
Venous malformations (MVs) are congenital abnormalities of the central or periphery caused by developmental errors at different stages of embryogenesis. Histologically they are characterized by large, venous-like vascular spaces. Scleroembolization constitutes the most widespread method in the treatment of venous malformations allowing good results with low invasiveness. Currently, Bleomycin (and its derivatives) is among the most widely used sclerosing agents for slow-flowing vascular malformations (venous and lymphatic malformations) because of the low rate of local serious adverse events such as swelling, necrosis, and nerve injury compared with others.
Official title: Trattamento Delle Malformazioni Venose a Basso Flusso Con l'Elettroscleroterapia. Studio Osservazionale Prospettico
Key Details
Gender
All
Age Range
16 Years - Any
Study Type
OBSERVATIONAL
Enrollment
65
Start Date
2023-10-28
Completion Date
2027-11-28
Last Updated
2024-10-29
Healthy Volunteers
No
Conditions
Interventions
Bleomycin
Using electroporation to infuse bleomycin in the lesion
Locations (1)
Istituto Ortopedico Rizzoli
Bologna, Emilia-Romagna, Italy